"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 1 | 4 |
| 1998 | 6 | 4 | 10 |
| 1999 | 8 | 2 | 10 |
| 2000 | 5 | 1 | 6 |
| 2001 | 9 | 2 | 11 |
| 2002 | 6 | 9 | 15 |
| 2003 | 13 | 16 | 29 |
| 2004 | 12 | 6 | 18 |
| 2005 | 22 | 14 | 36 |
| 2006 | 18 | 11 | 29 |
| 2007 | 17 | 13 | 30 |
| 2008 | 19 | 15 | 34 |
| 2009 | 22 | 19 | 41 |
| 2010 | 18 | 22 | 40 |
| 2011 | 15 | 25 | 40 |
| 2012 | 22 | 15 | 37 |
| 2013 | 28 | 20 | 48 |
| 2014 | 28 | 18 | 46 |
| 2015 | 40 | 21 | 61 |
| 2016 | 31 | 28 | 59 |
| 2017 | 33 | 19 | 52 |
| 2018 | 34 | 20 | 54 |
| 2019 | 35 | 29 | 64 |
| 2020 | 37 | 25 | 62 |
| 2021 | 33 | 26 | 59 |
| 2022 | 0 | 32 | 32 |
| 2023 | 1 | 10 | 11 |
| 2024 | 7 | 29 | 36 |
| 2025 | 3 | 4 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
Uncommon Tumors of the Lung: Recently Described and Rediscovered Tumors. Arch Pathol Lab Med. 2025 Apr 01; 149(4):e87-e92.
-
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation. Clin Cancer Res. 2025 Mar 17; 31(6):1057-1068.
-
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro Oncol. 2025 Mar 07; 27(3):616-624.
-
A Novel Sensitivity Maximization at a Given Specificity Method for Binary Classifications. Cancer Prev Res (Phila). 2025 Mar 03; 18(3):117-123.
-
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review. JAMA Oncol. 2025 Mar 01; 11(3):317-328.
-
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment. Biomark Med. 2025 Mar; 19(6):223-238.
-
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D. Clin Cancer Res. 2025 Feb 17; 31(4):667-677.
-
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
-
The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clin Cancer Res. 2025 Feb 03; 31(3):551-560.
-
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models. Clin Cancer Res. 2025 Feb 03; 31(3):573-587.